Hold Sun Pharmaceutical Industries: AK Prabhakar

AK Prabhakar of IDBI Capital told CNBC-TV18, "Pharmaceutical stocks have not performed for the year 2016 but in the last two years the EBITDA margins have dropped from 40 percent to 30 percent but these are bad times for pharma as a sector but going forward things will improve, so Sun Pharma is a hold."At 15:00 hrs Sun Pharmaceutical Industries was quoting at Rs 773, up Rs 1.10, or 0.14 percent on the BSE